Oncolytics Aligns with FDA on Planned Pivotal Anal Cancer Study
Go back to Oncolytics Aligns with FDA on Planned Pivotal Anal Cancer Study| Oncolytics Biotech, Inc. (NASDAQ: ONCY) | Delayed: 0.74 -0.03 (3.9%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.77 | 52 Week High | $1.37 | |||
| Open | $0.77 | 52 Week Low | $0.24 | |||
| Day High | $0.77 | P/E | N/A | |||
| Day Low | $0.73 | EPS | $0.00 | |||
| Volume | 764,275 | |||||
